Butyrate is a short‐chain fatty acid derived from the metabolism of indigestible
carbohydrates by the gut microbiota. Butyrate contributes to gut homeostasis, but it may also …

Diabetic kidney disease (DKD) remains the leading cause of the end-stage renal disease
and is a major burden on the healthcare system. The current understanding of the …

Butyrate, a main product of gut microbial fermentation, has been recognized as an important
mediator of gut microbiota regulation in whole body energy homeostasis. However, the …

Metagenomics studies have shown that type 2 diabetes (T2D) is associated with an altered
gut microbiota. Whereas different microbiota patterns have been observed in independent …

Butyrate is a short-chain fatty acid (SCFA) created within the intestinal lumen by bacterial
fermentation of largely undigested dietary carbohydrates. Its beneficial effects on cellular …

This review describes current evidence supporting butyrate impact in the homeostatic
regulation of the digestive ecosystem in health and inflammatory bowel diseases (IBDs) …

Butyrate is a key energy source for colonocytes and is produced by the gut microbiota
through fermentation of dietary fiber. Butyrate is a histone deacetylase inhibitor and also …

It is increasingly recognized that there is a connection between diet, intestinal microbiota,
intestinal barrier function and the low‐grade inflammation that characterizes the progression …

Metabolic syndrome (MetS) and the associated incidence of cardiovascular disease and
type 2 diabetes represents a significant contributor to morbidity and mortality worldwide …

Butyrate, a four-carbon short-chain fatty acid, is produced through microbial fermentation of
dietary fibers in the lower intestinal tract. Endogenous butyrate production, delivery, and …